Neuromuscular Blocking Agents
Skeletal Muscle Relaxants — Competitive & Depolarising Block, Reversal, Monitoring & Recent Advances
Past RGUHS + DNB + MPMSU + MUHS · 11
DNBOct '24
DNBOct '23
RGUHSNov '22
MPMSUAug '21
MUHSWinter '21
RGUHSNov '20
RGUHSNov '19
MPMSUJun '17
MPMSU2015
MUHSSummer '15
RGUHSOct '09
Introduction
- Skeletal muscle relaxants — drugs that reduce muscle tone or produce paralysis by acting either peripherally at the neuromuscular junction (NMJ) / muscle fibre, or centrally in the cerebrospinal axis.
- Neuromuscular blocking agents (NMBAs) — the peripherally acting, NMJ-blocking subset used chiefly with general anaesthetics to relax skeletal muscle for surgery and to facilitate endotracheal intubation; being charged quaternary compounds they do not cross the blood–brain barrier, so they lack CNS activity, analgesia or sedation.
- Two clinical classes — depolarising (only succinylcholine in general use) and non-depolarising / competitive (tubocurarine, the aminosteroids and the benzylisoquinoliniums).
- Historical note — curare = South-American arrow poison; Claude Bernard localised its action to the NMJ; Griffith & Johnson introduced curare for surgical relaxation in 1942.
Continue reading
Neuromuscular Blocking Agents
PharmaNotes Pro · LAQ
Sign in with your Google account. If you're already subscribed, the chapter unlocks immediately — otherwise, pick Monthly or Annual on the next step.